Fingerprint
Dive into the research topics of 'The McCAVE Trial: Vanucizumab plus mFOLFOX-6 Versus Bevacizumab plus mFOLFOX-6 in Patients with Previously Untreated Metastatic Colorectal Carcinoma (mCRC)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically